Gregory Bailey
CIK 1329505 · last filed 2026-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.02M
Companies
7
Total Filings
90
Lifetime Open-Market Net
-$43.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | Director | 126,910 | $1.84 | $233.5K | $504.8K | 15 | 2026-04-21 |
| BHVN | Director | 2,020,071 | $11.28 | $22.79M | -$23.12M | 34 | 2025-11-17 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Director | 0 | — | — | $0 | 1 | 2022-10-03 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 2 | 2021-06-23 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 950,922 | — | — | -$20.84M | 34 | 2012-11-01 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 131,000 | — | — | $0 | 2 | 2008-06-30 |
| Acer Therapeutics Inc. (OPXA) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
Recent Filings · Page 3 of 9
90 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-23 | BHVN | Buy (P) | +48,780 | $2.00M | EDGAR |
| 2024-04-04 | SER | Grant (A) | — | $0 | EDGAR |
| 2023-10-06 | BHVN | Buy (P) | +17,817 | $402.1K | EDGAR |
| 2023-05-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2022-10-26 | BHVN | Buy (P) | +200,000 | $2.10M | EDGAR |
| 2022-10-05 | — | Mixed | +1,307,971 | -$14 | |
| 2022-10-03 | Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Disp (D) | −2,583,658 | -$383.67M | EDGAR |
| 2022-08-22 | BHVN | Buy (P) | +38,000 | $5.63M | EDGAR |
| 2022-04-29 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2021-06-23 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.